Presentation Materials
Allergic Conjunctivitis
This module concentrates more in-depth on stepwise diagnosis, treatment and pharmacotherapy of allergic conjunctivitis.
Upon completion of this program, participants should be able to:
- Describe the major allergic eye diseases and their epidemiology
- Discuss the stepwise treatment of allergic rhinitis based on symptom severity
- Recognize the relationship between allergic rhinitis and allergic conjunctivitis
- Differentiate between the major allergic eye diseases
- Describe the treatments available for allergic conjunctivitis
Allergic Rhinitis
The first GLORIA module focuses on allergic rhinitis and its link to allergic conjunctivitis.
Upon completion of this program, participants should be able to:
- Describe the revised nomenclature for allergic rhinitis based on the ARIA document
- Discuss the differential diagnosis of allergic eye diseases
- Explain the mode of action of allergic conjunctivitis therapies
- Recommend a management plan for uncomplicated allergic conjunctivitis
Anaphylaxis
The module has been developed to provide a global overview on the pathophysiology, epidemiology, diagnosis and management of Anaphylaxis, a life-threatening allergic condition.
Upon completion of this program, participants should be able to:
- Discuss the different mechanisms which underlie anaphylaxis and the agents most likely to cause it
- Recognize the signs and symptoms of anaphylaxis
- Describe the principles of the emergency treatment of anaphylaxis
Angioedema
The Angioedema module reviews the pathophysiology, diagnosis, genetics and management of acquired and genetic forms of angioedema.
Upon completion of this program, participants should be able to:
- Outline the major causes and differential diagnosis of angioedema and hereditary angioedema
- Explain the treatment options for the management of hereditary and acquired angioedemas
Chronic Rhinosinusitis and Nasal Polyposis
PowerPoint Slides
This extensive module reviews the anatomy and physiology of the nose and paranasal sinuses. The definition and different phenotypes of rhinosinusitis and its pathogenesis are described. Diagnosis, concomitant problems, and medical management are discussed.
Upon completion of this program, participants should be able to:
- Understand the definition and different phenotypes of chronic rhinosinusitis
- Have knowledge of its pathogenesis
- Understand how to diagnose and treat rhinosinusitis
Drug Allergy
Slides (Part 1) Slides (Part 2)
This 2 part slide set covers definitions, epidemiology, risk factors, clinical manifestations with reference to pathogenesis/mechanisms, specific classes of drugs, diagnosis, treatment, desensitization and prevention.
Upon completion of Part 1 of this program, participants should be able to:
- Understand the difference between
- Adverse drug reaction
- Drug hypersensitivity
- Drug allergy
- Understand the epidemiology and risk factors for drug allergy
- Understand the pathogenesis and immunological mechanisms underlying the different phenotypes of drug allergy
Upon completion of Part 2 of this program, participants should be able to:
- Understand the clinical features of drug allergy in relation to the underlying pathogenetic mechanisms
- Understand the principles in the clinical diagnosis of drug allergy
- Understand the principles of diagnostic and provocation tests
- Manage drug allergies
Food Allergy
This module gives an extensive review of food allergy, from pathology and mechanisms of IgE-mediated and T-cell-mediated food allergy to diagnosis and clinical management.
Upon completion of this program, participants should be able to:
- Recognize the main pathogenic food allergens in adults and children
- Differentiate between IgE-mediated, cell-mediated and mixed IgE- and cell-mediated food-related diseases in different organ systems
- Discuss the diagnosis of food allergy and the limitations of diagnostic techniques
- Describe the treatment of food allergy
Immunotherapy
This evidence-based module provides an in-depth review of allergen immunotherapy, and reviews injection and local administration routes of immunotherapy.
Upon completion of this program, participants should be able to:
- Discuss the standardization of allergen extracts
- List the efficacy, safety and long-term benefits of immunotherapy
- Explain the mode of action of immunotherapy
- Describe injection and non-injection methods of immunotherapy
- Select suitable patients for immunotherapy
The Treatment of Severe Asthma
A new module investigating the pathophysiology, assessment and treatment of severe asthma.
Upon completion of this program, participants should be able to:
- Diagnose severe asthma
- Assess whether asthma is controlled
- Outline appropriate treatment strategies for optimal control of severe asthma
- Understand the risk factors for asthma exacerbations
- Identify the signs and symptoms of acute asthma
- Outline appropriate treatment strategies for optimal care of acute asthma exacerbations
Urticaria
This module focuses on Urticaria, reviewing the classification, pathophysiology, diagnosis and treatment of physical, chronic idiopathic and chronic urticarias.
Upon completion of this program, participants should be able to:
- Distinguish the various forms of physical urticaria
- Formulate a differential diagnosis and treatment plan for acute urticaria
- Describe the role of autoimmunity as a pathogenic mechanism for chronic urticaria
- Describe a therapeutic approach for patients with severe chronic idiopathic or chronic autoimmune urticaria.
- Distinguish urticarial vasculitis from other forms of chronic urticaria
|
US GLORIA is supported through unrestricted educational grants from: |
US GLORIA is jointly sponsored by: |
|
  |
